Global Cell and Gene Therapy Bioassay Services Market

Report ID : 1208 | Published : 2022-03-17 | Pages: | Format:

The global Cell and Gene Therapy Bioassay Services market size was accounted at USD 1.63 Bn in 2021; It is projected to grow at a compound annual growth rate (CAGR) of 15.0% from 2022 to 2030. Cell and gene therapy focuses on modifying genetic material to improve functioning or treat a disease.  These advanced therapies are one of the highest valued therapeutic segments within the biopharmaceutical industry and can address the most challenging diseases. Bioassay services play a critical role in the cell and gene therapy development process.

The key factors driving the growth of the cell and gene therapy bioassay services market include the high prevalence of chronic diseases and genetic disorders, the rising elderly population, the growing preference of patients toward personalized treatments, and increased technological advancements. Considering the demand for bioassays and the competitiveness of the biologics industry, many drug developers prefer outsourcing bioanalytical services that offer bioassay services for quick and efficient therapy analysis and development. Likely to compel the growth opportunities for the cell and gene therapy bioassay services market in the coming years.

However, the expensive bioassay services offered by the contract research organizations (CROs) may hinder the market growth over the forecast period.

The cell and gene therapy bioassay services market are classified based on the type of therapy, therapeutic area, scale of operation, and region. By type of therapy, the market comprises cell therapy and gene therapy. The cell therapy segment is expected to hold the maximum market share in the coming days owing to the rising demand and awareness regarding cell therapies. The market is classified into oncological, infectious, autoimmune, rare/ genetic, cardiovascular, metabolic, blood, neurological, ophthalmic disorders, and other therapeutic areas in terms of therapeutic area. The oncological segment is expected to be the fastest-growing segment of this market in the coming years, owing to the high prevalence of cancer and the rising aging population. The scale of operation segment is grouped into discovery, preclinical, and clinical. Regionally, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is projected to dominate this market over the forecast period, followed by Europe and Asia-Pacific.

Some of the key players operating in the cell and gene therapy bioassay services market are AnaBioTec (Belgium), CCRM (Canada), Nexelis (Canada), Pacific BioLabs (US), PPD Laboratories (North Carolina), Intertek Pharmaceutical Services (UK), Lonza (Switzerland), Porton Biopharma Ltd (UK), WuXi Advanced Therapies (US), Avomeen (US), Charles River Laboratories (US), Absorption Systems (US), BioAgilytix Labs (US), Catalent, Inc (US), Svar Life Science AB (Sweden), and others.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cell and Gene Therapy Bioassay Services Market Snapshot

Chapter 4. Global Cell and Gene Therapy Bioassay Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis

5.1. By Therapeutic Area & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Therapeutic Area:

5.2.1. Oncological

5.2.2. Infectious

5.2.3. Autoimmune

5.2.4. Rare / Genetic

5.2.5. Cardiovascular

5.2.6. Metabolic

5.2.7. Blood

5.2.8. Neurological

5.2.9. Ophthalmic Disorders

5.2.10. Other Therapeutic Areas

Chapter 6. Market Segmentation 3: By Therapy Estimates & Trend Analysis

6.1. By Therapy & Market Share, 2020& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Therapy:

6.2.1. Cell Therapy

6.2.2. Gene Therapy

Chapter 7. Market Segmentation 4: By Scale of Operations Estimates & Trend Analysis

7.1. By Scale of Operations & Market Share, 2020& 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Scale of Operations:

7.2.1. Discovery

7.2.2. Preclinical

7.2.3. Clinical

Chapter 8. Cell and Gene Therapy Bioassay Services Market Segmentation 5: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2019-2030

8.1.2. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts By Therapy, 2019-2030

8.1.3. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2019-2030

8.1.4. North America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by country, 2019-2030

8.2. Europe

8.2.1. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2019-2030

8.2.2. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2019-2030

8.2.3. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2019-2030

8.2.4. Europe Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2019-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2019-2030

8.3.2. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2019-2030

8.3.3. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2019-2030

8.3.4. Asia Pacific Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2019-2030

8.4. Latin America

8.4.1. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2019-2030

8.4.2. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2019-2030

8.4.3. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2019-2030

8.4.4. Latin America Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2019-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapeutic Area, 2019-2030

8.5.2. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) By Therapy, 2019-2030

8.5.3. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) estimates and forecasts by Scale of Operations, 2019-2030

8.5.4. Middle East & Africa Cell and Gene Therapy Bioassay Services Market revenue (US$ Million) by country, 2019-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. AnaBioTec

9.2.2. CCRM

9.2.3. Nexelis

9.2.4. Pacific BioLabs

9.2.5. PPD Laboratories

9.2.6. Intertek Pharmaceutical Services

9.2.7. Lonza

9.2.8. Porton Bio

9.2.9. WuXi Advanced Therapies

9.2.10. Avomeen

9.2.11. Charles River Laboratories

9.2.12. Absorption Systems

9.2.13. BioAgilytix Labs

9.2.14. Catalent, Inc

9.2.15. MilliporeSigma

9.2.16. Svar Life Science AB

Other Prominent Players

Global Cell and Gene Therapy Bioassay Services Market, by Type of Therapy, 2019-2030 (Value US$ Mn)

  • Cell Therapy
  • Gene Therapy

Global Cell and Gene Therapy Bioassay Services Market, by Therapeutic Area, 2019-2030 (Value US$ Mn)

  • Oncological
  • Infectious
  • Autoimmune
  • Rare / Genetic
  • Cardiovascular
  • Metabolic
  • Blood
  • Neurological
  • Ophthalmic Disorders
  • Other Therapeutic Areas

Global Cell and Gene Therapy Bioassay Services Market, by Scale of Operation, 2019-2030 (Value US$ Mn)

  • Discovery
  • Preclinical
  • Clinical

Global Cell and Gene Therapy Bioassay Services Market, by Region, 2019-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Cell and Gene Therapy Bioassay Services Market, by Country, 2019-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Cell and Gene Therapy Bioassay Services Market, by Country, 2019-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Cell and Gene Therapy Bioassay Services Market, by Country, 2019-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Cell and Gene Therapy Bioassay Services Market, by Country, 2019-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Cell and Gene Therapy Bioassay Services Market, by Country, 2019-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development

Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients